# Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome

> **NCT02025608** · PHASE4 · COMPLETED · sponsor: **Mauro Manconi** · enrollment: 20 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Pramipexole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02025608
- **Lead sponsor:** Mauro Manconi
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2016-12-31
- **Final completion:** 2016-12-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-01-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02025608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02025608, "Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02025608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*